[18F]FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer—A Pictorial Evaluation
Abstract
1. Introduction
2. Materials and Methods
2.1. Patient Population
2.2. TNM Staging System
- N2 is subdivided into N2a/N2b, representing involvement of single/of multiple ipsilateral mediastinal or subcarinal lymph node station(s), respectively.
- M1c is subdivided into M1c1/M1c2, representing multiple extrathoracic metastases in a single/in multiple organ system(s), respectively.
2.3. Correlation Between PET and Histopathological Findings
3. Results
3.1. Influence of the Ninth Edition of the IASLC TNM Staging System for Lung Cancer
3.2. Incorrect Identification of Primary Tumor and Metastasis
3.3. Assessment of a Lung Carcinoma as a Pulmonary Metastasis of Another Primary Tumor
3.4. Lymph Node Involvement Underestimated Due to Low Glucose Metabolism of the Lymph Nodes
3.5. Mismatch Between Imaging and Histological Tumor Size
3.6. Incorrect T Classification Due to Granulomas
3.7. Mismatch in Nodal Staging Due to Inflammatory Consolidations
3.8. Progression Between Preoperative PET/CT and Surgery
4. Discussion
- Misclassification of a primary lung carcinoma as a pulmonary metastasis from another primary tumor.
- Inaccurate measurement when the primary tumor is confluent with (malignant) lymph nodes.
- Measurement discrepancies between PET/CT and histopathology due to differing methodologies and subjectivity.
- Prolonged interval between preoperative PET/CT and surgery, allowing for tumor progression.
- False-positive findings caused by benign conditions such as inflammatory reactions or granulomas.
- False-negative findings due to low SUVmax in lymph nodes or the primary tumor.
- Preoperative PET/CT should be performed in all cases of lung carcinoma.
- The interval between PET/CT and surgery should be minimized to ensure imaging reflects the current extent of disease, particularly in tumors with rapid growth.
- In cases of diagnostic uncertainty, alternative cTNM staging scenarios should be considered and reported, taking into account the overall clinical context. Since TNM staging systems may be updated every few years, the most recent version (for lung cancer: IASLC TNM version 9) [12] has to be used and differences reported when necessary.
- In the presence of pneumonic or peritumoral infiltrates, or in cases of ventilation impairment (e.g., due to bronchial compression by a centrally located tumor), both pathologically enlarged lymph nodes (>1 cm in short-axis diameter) and lymph nodes with mildly to moderately increased glucose metabolism should be interpreted cautiously. These may more appropriately represent reactive changes rather than malignant involvement.
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- Expert Consensus, P.; Kidane, B.; Bott, M.; Spicer, J.; Backhus, L.; Chaft, J.; Chudgar, N.; Colson, Y.; D’Amico, T.A.; David, E.; et al. The American Association for Thoracic Surgery (AATS) 2023 Expert Consensus Document: Staging and multidisciplinary management of patients with early-stage non-small cell lung cancer. J. Thorac. Cardiovasc. Surg. 2023, 166, 637–654. [Google Scholar] [CrossRef]
- Dingemans, A.C.; Fruh, M.; Ardizzoni, A.; Besse, B.; Faivre-Finn, C.; Hendriks, L.E.; Lantuejoul, S.; Peters, S.; Reguart, N.; Rudin, C.M.; et al. Small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up(☆). Ann. Oncol. 2021, 32, 839–853. [Google Scholar] [CrossRef] [PubMed]
- Postmus, P.E.; Kerr, K.M.; Oudkerk, M.; Senan, S.; Waller, D.A.; Vansteenkiste, J.; Escriu, C.; Peters, S.; Committee, E.G. Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann. Oncol. 2017, 28, iv1–iv21. [Google Scholar] [CrossRef] [PubMed]
- Bille, A.; Pelosi, E.; Skanjeti, A.; Arena, V.; Errico, L.; Borasio, P.; Mancini, M.; Ardissone, F. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: Accuracy of integrated positron emission tomography and computed tomography. Eur. J. Cardiothorac. Surg. 2009, 36, 440–445. [Google Scholar] [CrossRef] [PubMed]
- Turkmen, C.; Sonmezoglu, K.; Toker, A.; Yilmazbayhan, D.; Dilege, S.; Halac, M.; Erelel, M.; Ece, T.; Mudun, A. The additional value of FDG PET imaging for distinguishing N0 or N1 from N2 stage in preoperative staging of non-small cell lung cancer in region where the prevalence of inflammatory lung disease is high. Clin. Nucl. Med. 2007, 32, 607–612. [Google Scholar] [CrossRef] [PubMed]
- Ebner, R.; Sheikh, G.T.; Brendel, M.; Ricke, J.; Cyran, C.C. ESR Essentials: Staging and restaging with FDG-PET/CT in oncology-practice recommendations by the European Society for Hybrid, Molecular and Translational Imaging. Eur. Radiol. 2025, 35, 1894–1902. [Google Scholar] [CrossRef]
- Lin, S.; Han, B.; Yu, L.; Shan, D.; Wang, R.; Ning, X. Comparison of PET-CT images with the histopathological picture of a resectable primary tumor for delineating GTV in nonsmall cell lung cancer. Nucl. Med. Commun. 2011, 32, 479–485. [Google Scholar] [CrossRef] [PubMed]
- Poettgen, C.; Theegarten, D.; Eberhardt, W.; Levegruen, S.; Gauler, T.; Krbek, T.; Stamatis, G.; Teschler, H.; Kuehl, H.; Bockisch, A.; et al. Correlation of PET/CT findings and histopathology after neoadjuvant therapy in non-small cell lung cancer. Oncology 2007, 73, 316–323. [Google Scholar] [CrossRef]
- Smith, D.E.; Fernandez Aramburu, J.; Da Lozzo, A.; Montagne, J.A.; Beveraggi, E.; Dietrich, A. Accuracy of positron emission tomography and computed tomography (PET/CT) in detecting nodal metastasis according to histology of non-small cell lung cancer. Updates Surg. 2019, 71, 741–746. [Google Scholar] [CrossRef]
- Viohl, N.; Steinert, M.; Freesmeyer, M.; Kuhnel, C.; Drescher, R. (18)F-FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer and as a Predictor of Lymph Node Involvement. J. Clin. Med. 2025, 14, 1324. [Google Scholar] [CrossRef]
- Rami-Porta, R.; Nishimura, K.K.; Giroux, D.J.; Detterbeck, F.; Cardillo, G.; Edwards, J.G.; Fong, K.M.; Giuliani, M.; Huang, J.; Kernstine, K.H., Sr.; et al. The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groups in the Forthcoming (Ninth) Edition of the TNM Classification for Lung Cancer. J. Thorac. Oncol. 2024, 19, 1007–1027. [Google Scholar] [CrossRef]
- International Association for the Study of Lung Cancer (IASLC). Staging Cards in Thoracic Oncology, 9th Ed. Available online: https://www.iaslc.org/research-education/publications-resources-guidelines/staging-cards-thoracic-oncology-9th-edition (accessed on 28 May 2025).
- Fong, K.M.; Rosenthal, A.; Giroux, D.J.; Nishimura, K.K.; Erasmus, J.; Lievens, Y.; Marino, M.; Marom, E.M.; Putora, P.M.; Singh, N.; et al. The International Association for the Study of Lung Cancer Staging Project for Lung Cancer: Proposals for the Revision of the M Descriptors in the Forthcoming Ninth Edition of the TNM Classification for Lung Cancer. J. Thorac. Oncol. 2024, 19, 786–802. [Google Scholar] [CrossRef]
- Asamura, H.; Nishimura, K.K.; Giroux, D.J.; Chansky, K.; Hoering, A.; Rusch, V.; Rami-Porta, R.; Araujo, L.H.; Beer, D.; Bertoglio, P.; et al. IASLC Lung Cancer Staging Project: The New Database to Inform Revisions in the Ninth Edition of the TNM Classification of Lung Cancer. J. Thorac. Oncol. 2023, 18, 564–575. [Google Scholar] [CrossRef]
- Erasmus, L.T.; Strange, C.D.; Ahuja, J.; Agrawal, R.; Shroff, G.S.; Marom, E.M.; Truong, M.T. Imaging of Lung Cancer Staging: TNM 9 Updates. Semin. Ultrasound CT MR 2024, 45, 410–419. [Google Scholar] [CrossRef] [PubMed]
- El-Sherief, A.H.; Lau, C.T.; Wu, C.C.; Drake, R.L.; Abbott, G.F.; Rice, T.W. International association for the study of lung cancer (IASLC) lymph node map: Radiologic review with CT illustration. Radiographics 2014, 34, 1680–1691. [Google Scholar] [CrossRef] [PubMed]
- Endoh, H.; Ichikawa, A.; Yamamoto, R.; Shiozawa, S.; Nishizawa, N.; Satoh, Y.; Oriuchi, N. Prognostic impact of preoperative FDG-PET positive lymph nodes in lung cancer. Int. J. Clin. Oncol. 2021, 26, 87–94. [Google Scholar] [CrossRef] [PubMed]
- Wang, B.Y.; Huang, J.Y.; Chen, H.C.; Lin, C.H.; Lin, S.H.; Hung, W.H.; Cheng, Y.F. The comparison between adenocarcinoma and squamous cell carcinoma in lung cancer patients. J. Cancer Res. Clin. Oncol. 2020, 146, 43–52. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Viohl, N.; Steinert, M.; Werner, A.; Kühnel, C.; Freesmeyer, M.; Drescher, R. [18F]FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer—A Pictorial Evaluation. J. Clin. Med. 2025, 14, 4449. https://doi.org/10.3390/jcm14134449
Viohl N, Steinert M, Werner A, Kühnel C, Freesmeyer M, Drescher R. [18F]FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer—A Pictorial Evaluation. Journal of Clinical Medicine. 2025; 14(13):4449. https://doi.org/10.3390/jcm14134449
Chicago/Turabian StyleViohl, Nathalie, Matthias Steinert, Anke Werner, Christian Kühnel, Martin Freesmeyer, and Robert Drescher. 2025. "[18F]FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer—A Pictorial Evaluation" Journal of Clinical Medicine 14, no. 13: 4449. https://doi.org/10.3390/jcm14134449
APA StyleViohl, N., Steinert, M., Werner, A., Kühnel, C., Freesmeyer, M., & Drescher, R. (2025). [18F]FDG PET/CT in the Preoperative Diagnostic and Staging of Lung Cancer—A Pictorial Evaluation. Journal of Clinical Medicine, 14(13), 4449. https://doi.org/10.3390/jcm14134449